Déborah Hirt - Concepedia

Author

Déborah Hirt

Université Paris Cité ORCID

Also Known As

D Hirt, D L Hirt, D. Hirt, Dborah Hirt, Deborah Hirt, Déborah Hirt, Déborah HIRT, Déborah Hirt

128

Publications

2.5K

Citations

H-Index

105

Concepts

All Affiliations

Université Paris Cité Assistance Publique – Hôpitaux de Paris Inserm Délégation Paris 5 Hôpital Cochin

About

Déborah Hirt is an author at Université Paris Cité specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	27	889
2	Public Health	7	7	251
3	Health Sciences	3	3	99
4	Education	1	1	17
5	Social Sciences	1	1	17

Déborah Hirt

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen Innocent Safeukui, Jean-Michel Corréas, Valentine Brousse, Blood	2008	177
Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2 Sihem Benaboud, Alain Pruvost, Patrick Coffié, Antimicrobial Agents and Chemotherapy	2010	135
An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study Déborah Hirt, Bart Van Overmeire, Jean‐Marc Tréluyer, British Journal of Clinical Pharmacology	2008	134
Extended pre-exposure prophylaxis with lopinavir–ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial Nicolas Nagot, Chipepo Kankasa, James Tumwine, The Lancet Maternal ImmunizationLopinavir–ritonavir Versus LamivudinePreventive MedicineTreatment And PreventionAntiviral Therapy	2015	83
Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109) Déborah Hirt, Saı̈k Urien, DK Ekouévi, Clinical Pharmacology & Therapeutics	2008	77
Prediction of human fetal pharmacokinetics using<i>ex vivo</i>human placenta perfusion studies and physiologically based models Maïlys De Sousa Mendes, Déborah Hirt, Cécile Vinot, British Journal of Clinical Pharmacology	2015	76
Physiologically‐based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women Maïlys De Sousa Mendes, Déborah Hirt, Elodie Valade, British Journal of Clinical Pharmacology	2015	65
Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach Célia Lloret‐Linares, Déborah Hirt, Christophe Bardin, Clinical Pharmacokinetics Population ApproachRoux-en-y Gastric BypassMedicinePostoperative Pain ManagementOral Morphine	2014	64
Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct. Déborah Hirt, Jorge H. Capdevila, John R. Falck, Journal of Clinical Investigation Cytochrome P450 MetabolitesPharmacotherapyExperimental PharmacologyOxidative StressMolecular Pharmacology	1989	64
A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways Maïlys De Sousa Mendes, Gabrielle Lui, Yi Zheng, Clinical Pharmacokinetics Several Cyp450 PathwaysPharmacokinetic ModelingDrug MetabolizedPharmacological StudyPhysiology	2016	58

Page 1